SCHEMBL6564618

SCHEMBL6564618

COC(=O)c1cc(NC(=O)Nc2cccc(OC)c2)ccc1OC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.53
TSHR P16473 1/20 0.53
MAPT P10636 9/20 0.51
NPC1 O15118 7/20 0.51
RAB9A P51151 7/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
ALDH1A1 P00352 2/20 0.48
HTT P42858 3/20 0.48
LMNA P02545 2/20 0.48
MAPK1 P28482 1/20 0.48
STAT1 P42224 1/20 0.48
MITF O75030 1/20 0.47
GAA P10253 1/20 0.47
CASP3 P42574 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
MGLL Q99685 1/20 0.46
CCR3 P51677 1/20 0.46
RAF1 P04049 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567997 0.92 MAPT (0.56) TP53TSHRMAPTNPC1RAB9A
SCHEMBL6564574 0.92 TSHR (0.55) TP53TSHRMAPTNPC1RAB9A
SCHEMBL6568077 0.92 KDM4E (0.52) TP53TSHRMAPTNPC1RAB9A
SCHEMBL6567653 0.91 CNR1 (0.56) TP53TSHRMAPTNPC1RAB9A
SCHEMBL6566884 0.90 MEN1 (0.55) TP53TSHRMAPTNPC1RAB9A
SCHEMBL6565825 0.88 KMT2A (0.54) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6565992 0.87 MEN1 (0.53) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6565683 0.87 KMT2A (0.50) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6568029 0.85 MEN1 (0.46) MAPTNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6567994 0.84 MAPT (0.47) TP53MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 TP53 4453/4885TSHR 1061/4885MAPT 4743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.